Ignite Creation Date:
2025-12-24 @ 7:56 PM
Ignite Modification Date:
2026-01-14 @ 4:07 AM
Study NCT ID:
NCT06029504
Status:
RECRUITING
Last Update Posted:
2023-12-06
First Post:
2023-09-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer (I)
Sponsor:
Rigshospitalet, Denmark
Organization:
Study Overview
Official Title:
Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer
Status:
RECRUITING
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SENTIVUC
Brief Summary:
The aim of this study is to investigate whether Sentinel Node biopsy can be performed without the use of lymphoscintigraphy and with ICG as a mono-tracer in women with vulvar cancer, unifocal tumor \< 4 cm (clinical stage IB and II). Further, to investigate the accuracy of combined PET-CT and ultrasound (US) of the groins with US-guided biopsy of suspicious lymph nodes for the identification of macro-metastases in women with vulvar cancer, unifocal tumor \< 4 cm.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: